Posts tagged “Biotech & Life Science”

Updated April 11, 2007

Premium Lock Phase Bioscience Replaces CEO with Former Trimeris President

PhaseBio Nixon Ellis replaces Gabriel Cipau. Park of Ellis’ new position is to raise more capital.

Updated April 10, 2007

Premium Lock Duke Researchers Develop Quick Test That Could Detect Exposure to Radiation

duke genome UniversityTech: ‘We have to be able to efficiently screen a large number of people for radiation exposure in order to respond effectively to a mass casualty event,’ Duke doctor says.

Updated April 10, 2007

Premium Lock Drug Firm BDSI Names Marketing Executive

BDSI Al Medwar, who once worked for Triangle Pharmaceuticals, joins BDSI from EMD Pharmaceuticals.

Updated April 10, 2007

Premium Lock Icagen Forms Discovery, Development Panel

Icagen Company brings in outside experts to help exploit its drug candidates.

April 9, 2007

Premium Lock Quintiles Dedicates New Lab in India

quintiles Opening of new facility marks 10 years of CRO doing business in that country

Updated April 6, 2007

Premium Lock Biofuels Builder: NCSU Building a Plant for Converting Plants

ethanol UniversityTech: $1.5 million grant from Golden LEAF Foundation to establish a pilot facility that will produce ethanol from plant cellulose.

Updated April 4, 2007

Premium Lock Good News for Pozen, GSK: Test Results Deliver 5% Boost to Stock Price

gsk Data published in Journal of American Medical Association show effectiveness of proposed migraine drug.

April 4, 2007

Premium Lock Test Results Show Proposed Migraine Drug Works, Pozen Says

Pozen News sparks 8% surge in Pozen stock in after-hours trading. Pozen is developing drug in partnership with GSK.

Updated April 4, 2007

Premium Lock Icagen Terminates Trial for Lead Drug; Stock Plummets

Icagen RTP-based pharmaceutical firm targeted sickle cell disease in Phase III trial.

Updated April 3, 2007

Premium Lock Biofuels Plan Seeks More Than $25 Million From State

A nine-point strategy seeks General Assembly support for research, development, construction of a pilot biofuels plant and support for a biofuels "acceleration facility."

April 3, 2007

Premium Lock NIH Awards Emory University $27M for Influenza Research Center

Pandemic Government to fund six centers as part of pandemic preparation.

Updated April 2, 2007

Premium Lock Trimeris Plans Further Layoffs

Trimeris In SEC filing, Trimeris says cuts will cost $1.1M. Some workers and responsibilities for HIV drug Fuzeon to be transferred to Roche.

April 2, 2007

Premium Lock Going Public: Merrion Pharmaceuticals Plans IPO

Merrion Drug delivery technology company, which has U.S. headquarters in Wilmington, aims to raise $46 million.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith